drugset / Trial / NCT00568113

N-Acetyl Cysteine for Prevention of Preterm Birth

NCT00568113

Phase 4 Completed 120 enrolled Assiut University
RandomizedParallel-groupOpen-labelPrevention

Summary

The antioxidant effect of N-Acetyl cysteine can abort the inflammatory cascade responsible for initiation of preterm labour especially among patients with reccurent preterm birth and patients having bacterial vaginosis

Timeline

Start
2007-07
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 0.6 g Oral
Subject hydroxyl progesterone caproate Unknown 150 mg Other

Indications

No indication recorded.